Condition: Mild Stroke · Sponsor: Second Affiliated Hospital of Soochow University
This study aims to evaluate whether initiating intravenous tirofiban within 48 hours of onset (with a 48-hour infusion), followed by sequential DAPT, can improve the likelihood of excellent functional outcomes (modified Rankin Scale score 0-1) in mild stroke patients, compared with standard DAPT therapy based on current guidelines.
This description comes directly from the study's public registry record.
Jijun Shi, M.D · +86 512 67783689 · shijijun2008@126.com
Yongjun Cao, M.D, PhD · yongjuncao@126.com
Always discuss trial participation with your own doctor first.
| Suzhou Municipal Hospital of Anhui Province | Suzhou, Anhui, China | Recruiting |
| Second Hospital of Hebei Medical University | Shijiazhuang, Hebei, China | Recruiting |
| Taikang Xian People's Hospital | Zhoukou, Henan, China | Recruiting |
| WuYuan County People's Hospital | Bayan Nur, Inner Mongolia, China | Recruiting |
| Huai'an First People's Hospital | Huai'an, Jiangsu, China | Recruiting |
| Jiangsu Province (Suqian) Hospital | Suqian, Jiangsu, China | Recruiting |
| Second Affiliated Hospital of Soochow University | Suzhou, Jiangsu, China | Recruiting |
| Affiliated Jiangsu Shengze Hospital of Nanjing Medical University | Suzhou, Jiangsu, China | Recruiting |
| Changshu No.1 People's Hospital | Suzhou, Jiangsu, China | Recruiting |
| First People's Hospital of Kunshan | Suzhou, Jiangsu, China | Recruiting |
| Suzhou Ninth People's Hospital | Suzhou, Jiangsu, China | Recruiting |
| Suzhou Xiangcheng People's Hospital | Suzhou, Jiangsu, China | Recruiting |
+ 6 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07095790